首页> 外文期刊>Majallah-i pizishki-i Urumiyah. >STUDY OF SERUM CYSTATIN C & CREATININE AS A RELIABLE MARKER FOR DIAGNOSIS OF IMPAIRED RENAL FUNCTION IN HYPERTENSIVE PATIENTS
【24h】

STUDY OF SERUM CYSTATIN C & CREATININE AS A RELIABLE MARKER FOR DIAGNOSIS OF IMPAIRED RENAL FUNCTION IN HYPERTENSIVE PATIENTS

机译:血清胱抑素C和肌酐作为诊断高血压患者肾功能受损的可靠标志物的研究

获取原文
           

摘要

Background & Aims : In the past serum creatinine concentration was used as one of the important markers for early detection of kidney disorders, however recent studies suggest serum cystatin C to be a better marker. Therefore in this study we compared the diagnostic value of cystatin C with serum creatinine to evaluate kidney function in patients with high blood pressure. Materials & Methods : This clinical trial study was conducted on high blood pressure patients referring to Mehrad hospital during 1387-1389 for checking their kidney function. Cobasmira automated analyzer was used to determine serum creatinine. The serum cystatin C was measured using ELISA method. The glomerular filtration rate was determined by measuring 24hr creatinine clearance. Positive and negative predictive value, sensitivity and specificity of cystatin C and creatinine were determined. Results : We studied 35 patients with high blood pressure (20 men and 15 women mean age, 49±11). This research work showed that positive predictive value and negative predictive value of creatinine were 94.3% and 31% respectively. And for cystatin C, were 92.3% and 44% respectively. The false positive and negative result for serum creatinine method were 2.8% and 31.4% and for cystatin C were 5.7% and 14.2% respectively. Total accuracy of cystatin C was 90% and creatinine was 65.8%. Finally based on results obtained from this study cystatin C had a sensitivity of 82 % and specificity of 57% and serum creatinine had sensitivity of 62 % and specificity of 41% for detecting crcl Conclusion : It seems that measurement of serum cystatin C can be applied to detect the reduction of kidney function in the primary stages of kidney disorder.
机译:背景与目的:过去,血清肌酐浓度被用作早期发现肾脏疾病的重要标志物之一,但是最近的研究表明血清胱抑素C是更好的标志物。因此,在这项研究中,我们将胱抑素C与血清肌酐的诊断价值进行了比较,以评估高血压患者的肾功能。材料与方法:该临床试验研究是在1387-1389年间对Mehrad医院的高血压患者进行的,以检查其肾功能。使用Cobasmira自动分析仪测定血清肌酐。使用ELISA法测定血清胱抑素C。通过测量24小时肌酐清除率来确定肾小球滤过率。测定了胱抑素C和肌酐的阳性和阴性预测值,敏感性和特异性。结果:我们研究了35例高血压患者(平均年龄20男15女,平均49±11)。这项研究工作表明,肌酐的阳性预测值和阴性预测值分别为94.3%和31%。胱抑素C分别为92.3%和44%。血清肌酐法的假阳性和阴性结果分别为2.8%和31.4%,胱抑素C的假阳性结果分别为5.7%和14.2%。胱抑素C的总准确度为90%,肌酐为65.8%。最后,根据本研究的结果,半胱氨酸蛋白酶抑制剂C对crcl的检测敏感性为82%,特异性为57%,血清肌酐敏感性为62%,特异性为41%。结论:似乎可以测定血清胱抑素C在肾脏疾病的主要阶段检测肾脏功能的降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号